India  

AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper

Video Credit: Cover Video STUDIO - Duration: 01:09s - Published
AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper

AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper

On Monday, the drugmaker announced the "exciting results" based on an analysis of trials in the UK and Brazil.


You Might Like

Related news from verified sources

Trials show third COVID-19 vaccine is cheaper, effective

AstraZeneca said on Monday that late-stage trials showed its coronavirus vaccine was up to 90 per...
Mid-Day - Published


Related videos from verified sources

Moderna seeks U.S., EU vaccine authorization [Video]

Moderna seeks U.S., EU vaccine authorization

[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious..

Credit: Reuters - Politics     Duration: 01:59Published
Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval [Video]

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval. Moderna will submit its coronavirus vaccine on Nov. 30. It is the second drugmaker to ask the FDA for emergency use..

Credit: Wibbitz Top Stories     Duration: 01:03Published
Covid-19 vaccine to be distributed initially in India says Serum Institute CEO [Video]

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO

The CEO of India's Serum Institute says India will get supplies of the Oxford-AstraZeneca vaccine that his organisation produces, first.

Credit: Newsflare STUDIO     Duration: 01:28Published